This report highlights all changes (additions and deletions) to the cvs caremark prescribing guide

Effective 10-01-2012
(Standard Drug List Reflects Exclusions)

This report highlights all changes (additions and deletions) to the CVS Caremark Prescribing Guide.

ADDITIONS:
Therapeutic Category/
Subcategory
Indication
Alternatives/Comments
Brand Agents:
Atelvia
To provide an additional once-weekly treatment option for osteoporosis that does not need to be administered on an Brilinta
Hematologic/ Brilinta is indicated to reduce the To provide an antiplatelet option that is superior to Plavix (clopidogrel) at reducing cardiovascular events in patients with ACS and is recommended by the American College of Cardiology Foundation and the American Heart Association for use in patients with unstable angina and To provide an additional NNRTI option with a lower risk of dyslipidemia and neuropsychiatric adverse events. This document contains references to brand-name prescription drugs that are trademarks or registered trademarks of pharmaceutical manufacturers not affiliated with CVS Caremark. 2012 Caremark, L.L.C. All rights reserved. 106-25956c 073012 Effective 10-01-2012
(Standard Drug List Reflects Exclusions)
Therapeutic Category/
Subcategory
Indication
Alternatives/Comments
Fluoxetine 60 mg
To provide an additional formulation of fluoxetine that may be more convenient for patients requiring fluoxetine Nervosa and Panic Disorder (with or without agoraphobia) in adults. adolescents aged 8 to 18 years and OCD in children and adolescents aged 7 to 17 years. Generic Agents:
fluvastatin
To provide an additional generic statin option with a low hypercholesterolemia and mixed dyslipidemia. irbesartan
To provide an additional generic angiotensin II receptor blocker (ARB) option with an indication for diabetic kidney elevated serum creatinine and proteinuria (> 300 mg/day) in patients with type 2 diabetes and hypertension. This document contains references to brand-name prescription drugs that are trademarks or registered trademarks of pharmaceutical manufacturers not affiliated with CVS Caremark. 2012 Caremark, L.L.C. All rights reserved. 106-25956c 073012 Effective 10-01-2012
(Standard Drug List Reflects Exclusions)
Therapeutic Category/
Subcategory
Indication
Alternatives/Comments
irbesartan/
To provide an additional generic ARB and diuretic hydrochloro-
thiazide

DELETIONS:
Therapeutic Category/
Subcategory
Indication
Alternatives/Comments
Brand Agents:
Iressa
Iressa (gefitinib) has been withdrawn from the market by the manufacturer due to lack of efficacy at prolonging advanced or metastatic non-small cell lung cancer after failure of both platinum-based and docetaxel chemotherapies who are benefiting or have benefited from Iressa. This document contains references to brand-name prescription drugs that are trademarks or registered trademarks of pharmaceutical manufacturers not affiliated with CVS Caremark. 2012 Caremark, L.L.C. All rights reserved. 106-25956c 073012 Effective 10-01-2012
(Standard Drug List Reflects Exclusions)
Therapeutic Category/
Subcategory
Indication
Alternatives/Comments
Metadate CD Central Nervous System/
Availability of other stimulant options for the treatment of Alternatives on the Prescribing Guide are amphetamine/dextroamphetamine mixed salts extended-release (Adderall XR), dexmethylphenidate (Focalin), dextroamphetamine (Dexedrine), dextroamphetamine extended-release (Dexedrine Spansule), methylphenidate (Methylin), methylphenidate (Ritalin), methylphenidate extended-release (Concerta), methylphenidate extended-release (Ritalin LA), methylphenidate extended-release 10 mg, Daytrana (methylphenidate transdermal), Focalin XR (dexmethylphenidate extended-release), Intuniv (guanfacine extended-release), Strattera (atomoxetine) and Vyvanse (lisdexamfetamine). Suboxone Film
Availability of other opioid dependence therapy options. An alternative on the Prescribing Guide is naltrexone This document contains references to brand-name prescription drugs that are trademarks or registered trademarks of pharmaceutical manufacturers not affiliated with CVS Caremark. 2012 Caremark, L.L.C. All rights reserved. 106-25956c 073012

Source: http://eacs.sharpschool.net/UserFiles/Servers/Server_3123024/File/10-2012%20Prescribing%20Guide%20Change%20Detail%20Report.pdf